THE CLINICAL UTILITY OF ANTI HUMAN LAMBDA CHAIN-BASED ELISA FOR THE DETECTION OF ANTI-INFLIXIMAB ANTIBODIES

(1) Chaim Sheba Medical Center

(2) Rambam Medical Center Health Care Campus



This item was part of the Taking IBD drugs back to the bench session at UEG Week Stockholm 2011

This item can be cited as: Gut 2011; 60 (Suppl 3) A51

You may be interested in:

Steroids: Past, present and future
English, Presentation, Clinical aspects, Crohn’s disease, Medical management, Colon, Future Horizons, 2010
Anti-TNF agents in IBD: Pharmacokinetics and Antibodies
English, Presentation, Medical management, Inflammatory bowel disease, Pharmacology, 'IBD-ology', 2012

Categorisation:

  • Format
    • Abstract
  • Language
    • English
  • Year
    • 2011